CO5271706A1 - Unidad de dosis de mirtazapina para el tratamiento de transtornos del sueno - Google Patents
Unidad de dosis de mirtazapina para el tratamiento de transtornos del suenoInfo
- Publication number
- CO5271706A1 CO5271706A1 CO01009904A CO01009904A CO5271706A1 CO 5271706 A1 CO5271706 A1 CO 5271706A1 CO 01009904 A CO01009904 A CO 01009904A CO 01009904 A CO01009904 A CO 01009904A CO 5271706 A1 CO5271706 A1 CO 5271706A1
- Authority
- CO
- Colombia
- Prior art keywords
- mirtazapine
- treatment
- disorders
- soil
- dose unit
- Prior art date
Links
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001785 mirtazapine Drugs 0.000 title abstract 3
- 239000002689 soil Substances 0.000 title 1
- 239000005022 packaging material Substances 0.000 abstract 2
- 208000019116 sleep disease Diseases 0.000 abstract 2
- 208000020685 sleep-wake disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00200499 | 2000-02-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5271706A1 true CO5271706A1 (es) | 2003-04-30 |
Family
ID=8171013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO01009904A CO5271706A1 (es) | 2000-02-11 | 2001-02-09 | Unidad de dosis de mirtazapina para el tratamiento de transtornos del sueno |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6933293B2 (enExample) |
| EP (4) | EP1257278B1 (enExample) |
| JP (1) | JP5039994B2 (enExample) |
| KR (1) | KR20020069371A (enExample) |
| CN (2) | CN1395487A (enExample) |
| AR (1) | AR027394A1 (enExample) |
| AT (1) | ATE317261T1 (enExample) |
| AU (1) | AU780439B2 (enExample) |
| BR (1) | BR0108261A (enExample) |
| CA (1) | CA2396209C (enExample) |
| CO (1) | CO5271706A1 (enExample) |
| CZ (1) | CZ302368B6 (enExample) |
| DE (1) | DE60117122T2 (enExample) |
| DK (1) | DK1257278T3 (enExample) |
| ES (1) | ES2258071T3 (enExample) |
| HK (1) | HK1049122B (enExample) |
| HU (1) | HUP0204391A3 (enExample) |
| IL (2) | IL150290A0 (enExample) |
| NO (1) | NO328007B1 (enExample) |
| PE (1) | PE20011080A1 (enExample) |
| PL (1) | PL206073B1 (enExample) |
| RU (1) | RU2270680C2 (enExample) |
| SK (1) | SK287396B6 (enExample) |
| WO (1) | WO2001058453A1 (enExample) |
| ZA (1) | ZA200205238B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040152055A1 (en) * | 2003-01-30 | 2004-08-05 | Gliessner Michael J.G. | Video based language learning system |
| UA83666C2 (ru) | 2003-07-10 | 2008-08-11 | Н.В. Органон | Способ получения энантиомерно чистого миртазапина |
| US20070298107A1 (en) * | 2003-11-25 | 2007-12-27 | Aurobindo Pharma Ltd. | Pharmaceutical Compositions of Mirtazapine |
| GB0417558D0 (en) * | 2004-08-06 | 2004-09-08 | Merck Sharp & Dohme | Novel combination therapy |
| KR100870381B1 (ko) * | 2004-10-14 | 2008-11-25 | 다이킨 고교 가부시키가이샤 | 분위기개변방법, 그리고 이에 이용되는 분무제 및 분무장치 |
| JP2006137748A (ja) * | 2004-10-14 | 2006-06-01 | Daikin Ind Ltd | 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置 |
| JP2007284363A (ja) * | 2006-04-13 | 2007-11-01 | Daikin Ind Ltd | 噴霧剤 |
| CA2684021A1 (en) | 2007-04-11 | 2008-10-23 | N.V. Organon | A method for the preparation of an enantiomer of a tetracyclic benzazepine |
| EP3261645B1 (en) | 2015-02-27 | 2021-04-28 | Dechra Limited | Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats |
| CN111053735A (zh) * | 2020-02-25 | 2020-04-24 | 上海阶平医院管理有限公司 | 一种治疗失眠的冷敷凝胶 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL189199C (nl) | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
| RU2107058C1 (ru) * | 1992-10-07 | 1998-03-20 | Акцо Нобель Н.В. | Способ выделения энантиомеров из рацемической смеси |
| IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
| EP0813873B1 (en) * | 1996-06-19 | 2002-02-13 | Akzo Nobel N.V. | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
| US6303595B1 (en) * | 1997-11-14 | 2001-10-16 | Akzo Nobel N.V. | Use of mirtazapine for treating sleep apneas |
-
2001
- 2001-02-06 US US10/203,232 patent/US6933293B2/en not_active Expired - Lifetime
- 2001-02-06 CN CN01803934A patent/CN1395487A/zh active Pending
- 2001-02-06 HU HU0204391A patent/HUP0204391A3/hu unknown
- 2001-02-06 CZ CZ20022330A patent/CZ302368B6/cs not_active IP Right Cessation
- 2001-02-06 RU RU2002124141/15A patent/RU2270680C2/ru not_active IP Right Cessation
- 2001-02-06 DK DK01902410T patent/DK1257278T3/da active
- 2001-02-06 EP EP01902410A patent/EP1257278B1/en not_active Expired - Lifetime
- 2001-02-06 JP JP2001557563A patent/JP5039994B2/ja not_active Expired - Lifetime
- 2001-02-06 EP EP05109549A patent/EP1658850A1/en not_active Withdrawn
- 2001-02-06 EP EP05109547A patent/EP1656937A1/en not_active Ceased
- 2001-02-06 PL PL356721A patent/PL206073B1/pl not_active IP Right Cessation
- 2001-02-06 CN CNA2008100056868A patent/CN101229170A/zh active Pending
- 2001-02-06 HK HK03101379.6A patent/HK1049122B/en not_active IP Right Cessation
- 2001-02-06 SK SK1144-2002A patent/SK287396B6/sk not_active IP Right Cessation
- 2001-02-06 CA CA002396209A patent/CA2396209C/en not_active Expired - Lifetime
- 2001-02-06 AT AT01902410T patent/ATE317261T1/de active
- 2001-02-06 KR KR1020027009536A patent/KR20020069371A/ko not_active Ceased
- 2001-02-06 BR BR0108261-2A patent/BR0108261A/pt not_active Application Discontinuation
- 2001-02-06 AU AU30247/01A patent/AU780439B2/en not_active Expired
- 2001-02-06 ES ES01902410T patent/ES2258071T3/es not_active Expired - Lifetime
- 2001-02-06 IL IL15029001A patent/IL150290A0/xx unknown
- 2001-02-06 DE DE60117122T patent/DE60117122T2/de not_active Expired - Lifetime
- 2001-02-06 WO PCT/EP2001/001221 patent/WO2001058453A1/en not_active Ceased
- 2001-02-06 EP EP10178745A patent/EP2283840A1/en not_active Withdrawn
- 2001-02-08 PE PE2001000141A patent/PE20011080A1/es not_active Application Discontinuation
- 2001-02-09 CO CO01009904A patent/CO5271706A1/es not_active Application Discontinuation
- 2001-02-09 AR ARP010100585A patent/AR027394A1/es unknown
-
2002
- 2002-06-18 IL IL150290A patent/IL150290A/en not_active IP Right Cessation
- 2002-06-28 ZA ZA200205238A patent/ZA200205238B/en unknown
- 2002-08-09 NO NO20023803A patent/NO328007B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1112361T1 (el) | Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743 | |
| CO5200840A1 (es) | Combinacion de sustancias activas con clonidina | |
| MX9203444A (es) | Medicamentos. | |
| CL2004000931A1 (es) | Pelicula consumible adaptada para adherirse y disolverse en la cavidad bucal que comprende un almidon modificado y un agente farmaceuticamente activo. | |
| UY27789A1 (es) | Metodos y modalidades de dosificación para la liberación controlada de oxicodona. | |
| GT200000041A (es) | Uso de inhibidores de cyp2d6 en terapias de combinacion. | |
| CL2008003941A1 (es) | Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden compulsivo obsesivo. | |
| UY25544A1 (es) | Forma de dosificación de nefazodona | |
| ES2167061T3 (es) | Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino. | |
| CO4560547A1 (es) | Una forma de dosis de azitromicina y un metodo de trata- miento de una infeccion microbiana que involucra la adminis- tracion de azitromicina | |
| SV2006002256A (es) | Uso de un anticuerpo para tratar la vasculitis | |
| CO5410187A1 (es) | Formulacion oral de dosis unica de espinosad | |
| PE20060002A1 (es) | Combinaciones antineoplasicas de cci-779 y rituximab | |
| ES2195638T3 (es) | Preparaciones de combinaciones farmaceuticas en forma solida de dosificacion que contienen cardevilol e hidroclorotiazida. | |
| CO5271706A1 (es) | Unidad de dosis de mirtazapina para el tratamiento de transtornos del sueno | |
| DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
| ECSP078014A (es) | Regimen de dosificacion para prasugrel | |
| UY27416A1 (es) | Uso de bibn4096 en combinación con otros fármacos antimigranosos para el tratamiento de migrana | |
| RU2002122084A (ru) | Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных растройств | |
| ES2422286T3 (es) | Uso de apamina para tratar la enfermedad de Parkinson | |
| AR036877A1 (es) | Formulacion farmaceutica | |
| AR023597A1 (es) | Utilizacion del saredutant y de sus sales farmaceuticamente aceptables para la preparacion de medicamentos utiles en el tratamiento o la prevencion delconjunto de los trastornos del humor, de los trastornos de adaptacion o de los trastornos mixtos ansiedad-depresion | |
| CL2002001701A1 (es) | Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno. | |
| ECSP003685A (es) | Formulaciones orales de liberacion controlada | |
| AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |